ACTIVE

ULTIMEDI

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-141,2 k €

-142.7% YoY

Revenue

11,3 M €

+138.7% YoY

Equity

1,9 M €

-6.9% YoY

Workforce

18,4 ETP

+7.6% YoY

What does ULTIMEDI do?

ULTIMEDI is a Private limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wingene. It employs on average 18,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0834.340.946

Incorporation

04/03/2011

Legal form

Private limited company

Registered office

Flandria 5
8750 Wingene · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

18,4 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods

Joint committees (4)

100
10000
200
20000

Signals

Low riskGood liquidityHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012
Income statement
Revenue	11,3 M €	+139%	4,7 M €		–		–		–		–		–		–		–		–		–		–		–		2,4 M €		–
EBITDA	-231,8 k €	-135%	658,8 k €	+94.6%	338,6 k €	-59.7%	840,1 k €	-26.3%	1,1 M €	+11.4%	1 M €	+24.6%	821 k €	+328%	192 k €	-6.8%	206 k €	+3.3%	199,4 k €	+8.6%	183,5 k €	-0.3%	184,1 k €	+4.4%	176,3 k €	+8.3%	162,8 k €	+137%	68,8 k €
Operating result	-178,9 k €	-145%	394,6 k €	+43.0%	275,9 k €	-63.3%	751,5 k €	-28.3%	1 M €	+15.1%	910,7 k €	+31.0%	695,3 k €	+690%	88 k €	-23.9%	115,6 k €	-26.6%	157,4 k €	-6.0%	167,5 k €	+2.6%	163,3 k €	-0.7%	164,5 k €	+6.9%	153,9 k €	+125%	68,4 k €
Net result	-141,2 k €	-143%	330,9 k €	+6.1%	311,9 k €	-58.6%	753,2 k €	+1.2%	744,3 k €	+7.5%	692,2 k €	+46.2%	473,6 k €	+613%	66,4 k €	-44.7%	120,1 k €	+0.5%	119,6 k €	-10.4%	133,5 k €	+5.0%	127,1 k €	+9.5%	116,1 k €	+0.5%	115,6 k €	+141%	47,9 k €
Balance sheet
Equity	1,9 M €	-6.9%	2 M €	+19.3%	1,7 M €	-48.1%	3,3 M €	+29.6%	2,5 M €	+41.3%	1,8 M €	+62.3%	1,1 M €	+74.4%	636,8 k €	+11.6%	570,4 k €	+26.7%	450,2 k €	+36.2%	330,6 k €	+67.7%	197,2 k €	+2.7%	192,1 k €	+65.7%	115,9 k €	+188%	40,3 k €
Total assets	7 M €	+82.0%	3,8 M €	-9.5%	4,2 M €	-8.3%	4,6 M €	-10.0%	5,1 M €	+23.3%	4,2 M €	+32.2%	3,2 M €	+77.9%	1,8 M €	+0.7%	1,8 M €	+74.8%	1 M €	+35.3%	744,9 k €	+32.3%	563 k €	-0.4%	565,1 k €	+42.5%	396,6 k €	-5.9%	421,7 k €
Cash	42,1 k €	-62.3%	111,8 k €	-65.3%	321,9 k €	-38.3%	522,1 k €	-60.2%	1,3 M €	+4.0%	1,3 M €	+16.2%	1,1 M €	+381%	225,5 k €	-4.1%	235,2 k €	+51.2%	155,6 k €	+18.7%	131 k €	+28.5%	101,9 k €	+25.1%	81,5 k €	-13.6%	94,3 k €	-60.9%	241,2 k €
Debts	5 M €	+178%	1,8 M €	-29.0%	2,5 M €	+90.5%	1,3 M €	-48.8%	2,6 M €	+9.7%	2,4 M €	+15.8%	2 M €	+79.9%	1,1 M €	-4.5%	1,2 M €	+114%	557,4 k €	+34.5%	414,3 k €	+13.3%	365,8 k €	-1.9%	373 k €	+42.5%	261,7 k €	-12.3%	298,5 k €
Other
Workforce	18,4 ETP	+7.6%	17,1 ETP	-2.3%	17,5 ETP	+25.9%	13,9 ETP	+10.3%	12,6 ETP	+26.0%	10,0 ETP	+8.7%	9,2 ETP	+19.5%	7,7 ETP	+22.2%	6,3 ETP	+26.0%	5,0 ETP	+25.0%	4,0 ETP	+100%	2,0 ETP	+53.8%	1,3 ETP	+30.0%	1,0 ETP	+66.7%	0,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 6 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 19 août 2025 · 0799.344.237

Represented by Benoit Devroe

Active

Bobbie Company

Managing director · since 16 mars 2023 · until 19 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active

Cecile Hoogmartens

Director · since 16 mars 2023

Active

CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris VERSTRAETE

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended

Bobbie Company

Director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended

CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Ended

Annual accounts

Full financial information

	2025	2024	2024	2023	2022	2021
Type of account	Full model	Full model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020
Closing of the financial year	31/12/2025	31/12/2024	30/06/2024	30/06/2023	30/06/2022	30/06/2021
Length of the financial year	12 months	6 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	10/07/2025	30/01/2025	31/01/2024	30/01/2023	31/01/2022
General meeting	30/06/2026	27/06/2025	27/12/2024	29/12/2023	30/12/2022	31/12/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

15 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	20/07/2026	Dutch	PDF
Full model	31/12/2024	27/06/2025	10/07/2025	Dutch	PDF
Abridged model	30/06/2024	27/12/2024	30/01/2025	Dutch	PDF
Abridged model	30/06/2023	29/12/2023	31/01/2024	Dutch	PDF
Abridged model	30/06/2022	30/12/2022	30/01/2023	Dutch	PDF
Abridged model	30/06/2021	31/12/2021	31/01/2022	Dutch	PDF
Abridged model	30/06/2020	28/12/2020	29/01/2021	Dutch	PDF
Abridged model	30/06/2019	27/12/2019	31/01/2020	Dutch	PDF
Abridged model	30/06/2018	25/12/2018	31/01/2019	Dutch	PDF
Abridged model	30/06/2017	25/12/2017	31/01/2018	Dutch	PDF
Abridged model	30/06/2016	30/12/2016	26/01/2017	Dutch	PDF
Abridged model	30/06/2015	25/12/2015	14/01/2016	Dutch	PDF
Abridged model	30/06/2014	24/12/2014	04/02/2015	Dutch	PDF
Abridged model	30/06/2013	24/12/2013	14/02/2014	Dutch	PDF
Abridged model	30/06/2012	25/12/2012	14/02/2013	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 6 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 19 août 2025 · 0799.344.237

Represented by Benoit Devroe

Active

Bobbie Company

Managing director · since 16 mars 2023 · until 19 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active

Cecile Hoogmartens

Director · since 16 mars 2023

Active

CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris VERSTRAETE

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended

Bobbie Company

Director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended

CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates10/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other03/01/2025
ALGEMENE VERGADERING - BOEKJAAR
PDF
Other13/05/2024
BOEKJAAR - DIVERSEN
PDF
Other11/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Mandates04/04/2023
ONTSLAGEN - BENOEMINGEN
PDF
Registered office20/12/2019
MAATSCHAPPELIJKE ZETEL
PDF
Other18/03/2011
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-141,2 k €↓
2024
Annual accounts 2024330,9 k €↑
2024
Annual accounts 2024311,9 k €↓
2023
Annual accounts 2023753,2 k €↑
2022
Annual accounts 2022744,3 k €↑
2021
Annual accounts 2021692,2 k €↑
2020
Annual accounts 2020473,6 k €↑
2019
Annual accounts 201966,4 k €↓
2018
Annual accounts 2018120,1 k €↑
2017
Annual accounts 2017119,6 k €↓
2016
Annual accounts 2016133,5 k €↑
2015
Annual accounts 2015127,1 k €↑
2014
Annual accounts 2014116,1 k €↑
2013
Annual accounts 2013115,6 k €↑
2012
Annual accounts 201247,9 k €
04/03/2011
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ULTIMEDI

Overview

What does ULTIMEDI do?

Trend over 15 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline